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Associative mechanisms seem to build up over repeated mood
episodes in bipolar disorder, such that later episodes are both
more readily triggered by psychosocial circumstances previously
linked to mood changes and are also less likely to be mediated by
psychosocial processes.1–3 This suggests that cognitive–behavioural
interventions could be more effective if offered earlier in the course
of the disorder before strong associative links to bipolar emotional
states are established. Consistent with this, a post hoc analysis of
data from a large trial of cognitive–behavioural therapy (CBT)
for relapse prevention in bipolar disorder found a significant
benefit only for those with fewer episodes.4 There is further evidence
that earlier onset of bipolar disorder is linked to worse clinical
outcomes, leading to calls for more timely detection and inter-
vention.5,6 In addition to adaptations to facilitate early treatment,
existing CBT interventions also need to accommodate the shift in
focus from primarily symptom-reduction outcomes to include
more personal-recovery outcomes, supported by both service users
and UK government policy.7–9 This study is the first to evaluate
the feasibility and effectiveness of an adapted CBT intervention
intended to enhance personal recovery and reduce relapse for
individuals within the first 5 years of bipolar disorder onset.
Method
This study was reviewed and approved by the UK NHS Ethics
Committee process (REC ref: 10/H1014/60). A detailed protocol
for the study has already been published.10
Trial design
This is a rater-masked pilot randomised controlled trial that
compared up to 18 h of recovery-focused CBT for bipolar disorder
offered in addition to treatment as usual (TAU) with TAU only.
The trial was conducted across 11 NHS trusts in the North
West of England: participants were recruited between 9 February
2011 and 19 January 2012. Individuals were randomised by an
independent clinical trials unit, with minimisation on number
of previous episodes (1–6, 46) and current mood symptoms
(depression: Hamilton Rating Scale for Depression (HRSD)11
0–13, 513 and mania: Bech–Rafaelsen Mania Scale (MAS)12
0–20, 420), all significant predictors of therapy outcome.4,13,14
Researchers were masked to treatment condition. To maximise
masking, researchers and therapists occupied different offices,
researchers were not involved in randomisation and participants
were reminded not to talk about treatment allocation by researchers.
Fourteen breaks to masking occurred; in each case another masked
researcher undertook all remaining assessments. In total, 79%
(n=53) of participants had masked assessments throughout and
95% of all assessment sessions were confirmed as definitely
masked. As a pilot study, the sample size was selected to determine
feasibility and acceptability and to provide indicative information
on potential clinical effectiveness for a future definitive trial (for
which an attention control condition would be considered along
with longer follow-up).
Recruitment
Community mental health teams, out-patient clinics, general
practice surgeries, primary care mental health teams and
voluntary services were approached to identify potential
participants. Care coordinators, research nurses and research
development officers were approached in order to contact
potential participants in the first instance. The study was also
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Background
Despite evidence for the effectiveness of structured
psychological therapies for bipolar disorder no psychological
interventions have been specifically designed to enhance
personal recovery for individuals with recent-onset bipolar
disorder.
Aims
A pilot study to assess the feasibility and effectiveness of a
new intervention, recovery-focused cognitive–behavioural
therapy (CBT), designed in collaboration with individuals with
recent-onset bipolar disorder intended to improve clinical
and personal recovery outcomes.
Method
A single, blind randomised controlled trial compared
treatment as usual (TAU) with recovery-focused CBT plus
TAU (n=67).
Results
Recruitment and follow-up rates within 10% of pre-planned
targets to 12-month follow-up were achieved. An average of
14.15 h (s.d. = 4.21) of recovery-focused CBT were attended
out of a potential maximum of 18 h. Compared with TAU,
recovery-focused CBT significantly improved personal
recovery up to 12-month follow-up (Bipolar Recovery
Questionnaire mean score 310.87, 95% CI 75.00–546.74
(s.e. = 120.34), P=0.010, d= 0.62) and increased time to
any mood relapse during up to 15 months follow-up
(w2 = 7.64, P50.006, estimated hazard ratio (HR) = 0.38,
95% CI 0.18–0.78). Groups did not differ with respect
to medication adherence.
Conclusions
Recovery-focused CBT seems promising with respect to
feasibility and potential clinical effectiveness. Clinical- and
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advertised in local media and posters and leaflets distributed in
both National Health Service (NHS) and non-NHS sites to
maximise participant access. Written informed consent was
obtained from all participants.
Inclusion/exclusion criteria
All participants met the following inclusion criteria: (a) DSM-IV15
diagnosis of primary bipolar disorder with onset in past 5 years,
assessed using the Structural Clinical Interview for DSM-IV
(SCID);16 (b) sufficient understanding of written and spoken
English in order to provide consent, engage with interviews and
use the intervention; and (c) aged between 18 and 65 years.
Exclusion criteria included: manic, hypomanic, depressed or
mixed episode currently or in the past 4 weeks, so that individuals
were able to engage with a therapy focused on personal recovery
outcomes rather than acute symptom management.
Outcome measures
Feasibility and acceptability of delivering the recovery-focused
CBT intervention to individuals with recent-onset bipolar disorder
(onset in past 5 years) was measured by the following factors: levels
of recruitment into the trial; retention of participants in both arms
of the study and adherence to and completion of the intervention.
Participants were followed up for up to 15 months from initial
randomisation with telephone assessments every 3 months to
evaluate bipolar relapse and observer-rated mood (SCID-LIFE,17
HRSD11 and MAS12). Self-reported recovery (Bipolar Recovery
Questionnaire, BRQ18) and additional clinical measures were
assessed at baseline and then at 6 and 12 months (see below for
detail on the assessments used). It was originally intended to
collect both self-report and observer-reported data on all
participants for up to 18 months’ follow-up. However, it proved
impossible to achieve this final intended assessment within the
trial funding period because of delays with staff recruitment and
trust research and development approvals and limited therapist
capacity. Recovery data (self-report) is reported for up to 12 months
and relapse/observer-rated symptom data for up to 15 months (12
months for 17 participants whose 15-month assessment point fell
after the study period).
Primary clinical outcomes
Primary clinical outcomes (as pre-specified in the published
protocol10) assessed the effect of recovery-focused CBT on self-
reported recovery measured by the BRQ (33-item version used,
correlates 0.997 with the published 36-item version18), time to
bipolar relapse measured by the SCID-LIFE and mood symptoms
as measured by the HRSD and MAS. The BRQ items were scored
on a 0–100 scale (higher score, sum of items, indicates higher
personal recovery).
Secondary clinical outcomes
Secondary outcomes evaluated were the impact of recovery-
focused CBT on the following: (a) quality of life (Brief Quality
of Life in Bipolar Disorder Questionnaire, QoL.BD)19 and social
functioning (Personal and Social Functioning Scale; PSP);20 (b)
self-reported mood symptoms as measured by the Beck
Depression Inventory (BDI-II)21 and Internal States Scale (ISS;
activation (ISS-A) and wellbeing (ISS-W) subscales);22 (c)
medication adherence (days missed for prescribed medication –
self-report) measured by the Stephenson Medical Adherence
Questionnaire (MEDAD).23
Therapeutic alliance and adherence
to treatment protocol
Therapy engagement was assessed by attendance rates and
Working Alliance Inventory (short-form, therapist and client
versions; WAI-S) completed at sessions 4, 8, and 17 to sample
from early, middle and later phases of therapy.24 Treatment fidelity
was assessed by both the Cognitive Therapy Scale Revised version
(CTS-R)25 and the Recovery Fidelity Scale, specifically designed for
the current study (details available from the authors on request),
to indicate adherence to the therapy’s recovery focus, again
sampled across early, middle and late phases of therapy.
Individual recovery-focused CBT intervention
The intervention was informed by key components of effective
CBT interventions26 and findings from a case series study of
CBT for recently diagnosed bipolar disorder.27 Key features
include flexible engagement, allowing time for full consideration
of the meaning of diagnosis to the client, coping skills reviews
around subsyndromal exacerbations as well as prior episodes
and considering the role of appraisals of fluctuations in affect.
Therapy manual development was also informed by qualitative
interviews with individuals about their experiences of recovery
in bipolar disorder and focus groups with individuals with bipolar
disorder to consult on the draft content of therapy, format and
supporting materials for the recovery-focused CBT intervention.
The intervention was delivered by mental health professionals
trained to British Association for Behavioural and Cognitive
Psychotherapies accreditation level in CBTor equivalent. Duration
of therapy was up to 18 h delivered over approximately 6 months
at clients’ homes or mental health facilities, according to personal
preference. Initial sessions were weekly, with later sessions
fortnightly, and typically lasted 45–60min.
The following elements are contained within the recovery-
focused CBT manual and reflect elements typically addressed in
the course of therapy, although the relative emphasis on each
element is informed by the client’s formulation: introducing the
recovery approach to clients; collection of information about
current and historical mood and functioning; meaning and
relevance of diagnosis; identification of recovery-informed therapy
goals; initial formulation of relationships between mood
experiences and progress towards recovery goals; identification
and application of CBT techniques to address and facilitate
positive coping; consideration of wider functioning issues in
relation to recovery; development and completion of recovery
plan; sharing lessons from therapy with key stakeholders.
The therapy approach differs from standard CBT for bipolar
disorder in the following ways: explicit focus on eliciting client-
focused goals rather than presuming a target of relapse prevention;
formulation-driven idiosyncratic approach rather than applying a
very similar model of bipolar experience across clients; freedom
to work within whatever model the client brings; openness to
addressing functioning and comorbidity issues as well as mood
problems; emphasis on supporting clients to move away from
self-critical and/or stigmatising language, especially around
diagnosis and behaviour in acute episodes.
In both groups, TAU was characterised by routine medication
(mood stabilisers, antipsychotics and antidepressants). Over two-
thirds of participants received their medical care from secondary
care services, mainly through a combination of maintenance
appointments from their responsible clinician and support from
a community mental health team (CMHT). A small number of
participants were being treated by a psychiatrist only without
regular CMHT contact. The remainder of participants reported
attending primary care services.
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Therapists
Recovery-focused CBT was delivered by four therapists, all of
whom were qualified clinical psychologists. One therapist saw
the majority of clients (G.S. n= 21), the other therapists saw
two or five clients each (M.W. n= 2; J.K. and J.M. n= 5). All
therapists received training in the use of the recovery-focused
CBT manual and attended weekly therapy supervision.
Statistical analysis
Analyses were carried out using Stata version 11 for Windows
and were pre-specified.10 All therapy effects were estimated using
a random-effects (random intercepts) model, assuming that the
effects were the same for each follow-up time (having first checked
that there was no significant therapy by follow-up time inter-
action). The baseline value of the relevant outcome measure was
used as a covariate. The intention-to-treat principle was followed
throughout. If there had been a significant number of participants
not attending their allocated sessions, this would have been
supplemented by estimation of the therapy effects in those
participants who actually receive the intervention via estimation
of the Complier-Average Causal effect (CACE).28,29 However, this
proved to be unnecessary. Time to relapse was assessed by survival
analysis (differences between groups being evaluated using the
logrank test; hazard ratios (HRs) were estimated using a Cox
proportional hazards model). Missing data were assumed to be
missing at random (ignorable) and automatically allowed for in
fitting the random-effects or analysis of covariance models.30
Results
Feasibility outcomes
Feasibility outcomes for this study were assessed by recruitment
and retention rates in both arms and participation in the
recovery-focused CBT for those in the treatment arm. Participant
flow is indicated in Fig. 1. Of 125 screened for eligibility, 67
individuals were randomised to recovery-focused CBT or TAU.
Of those not randomised, the majority declined the opportunity
to participate or did not respond to initial contact (n= 35, 19
did not respond to initial contact, 4 refused to participate in the
screening for the study, 12 could not commit to the full study
period including follow-up assessments). The remainder did not
meet study criteria because of a duration of illness greater than
5 years (n= 14), currently in an episode (n=6), older than 65
years (n= 2) or already participating in another intervention study
(n= 1).
Of the 67 participants randomised, 78% (n= 52) were retained
to end of therapy follow-up at 6 months, 76% (n=51) to 9-month
follow-up and 67% (n=45) at 12-month follow-up. The 15-month
follow-up period was tapered as study funding terminated before
this assessment became due for 17 participants. Of those eligible,
62% (n= 31) completed 15-month follow-up.
Of the 33 participants allocated to recovery-focused CBT, 32
attended at least six sessions (mean 14.15 h, s.d. = 4.21). Only four
clients expressed a preference not to receive therapy at home
because of either family conflicts or practical convenience (one
was seen in a community mental health team, two at their GP
practice and one at their place of work). Working alliance ratings
were obtained from therapists for 69 sessions and from clients for
51 sessions (47 paired ratings). Alliance as rated by therapists was
56.55 (s.d.= 4.94) at session 4; 58.84 (s.d.= 4.76) at session 8; and
61.76 (s.d. = 4.84) at session 17. At each stage of therapy clients’
ratings were higher than those of therapists: 64.72 (s.d. = 7.01);
66.35 (s.d. = 7.66); and 71 (s.d. = 5.51), respectively. Alliance
ratings are comparable with those observed for psychological
therapy in mild and complex patient groups.31,32 Therapist
protocol adherence was independently assessed for 33 randomly
selected session tapes. Adherence to the therapy protocol was
91% (Recovery Fidelity Scale), whereas the mean score for CTS-R
was 35.4 (s.d. = 7.9), which is above the established threshold
criteria for competence.33 Recovery Fidelity Scale and CTS-R scores
were moderately but significantly correlated (r=0.467, P50.006).
Participant characteristics
Participants were on average 540 years old and predominantly
female (70%, n=47) in both groups, and received their clinical
diagnosis of bipolar disorder within the past 2–3 years (Table 1).
A small proportion of participants had an early age at onset of
bipolar disorder (518 years, n= 6 TAU group; n=7 recovery-
focused CBT group). The majority of participants (79%, n=53)
had a diagnosis of bipolar I disorder (the remainder had bipolar
II disorder) and subclinical scores on observer measures of
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Fig. 1 CONSORT diagram.
Recovery-focused cognitive–behavioural therapy for bipolar disorder
a mixture of antidepressants, mood stabilisers and antipsychotics.
Care team arrangements were similar, with the majority (75%,
n= 50) of both groups receiving care from a community mental
health team or primarily from a psychiatrist. A minority (25%,
n= 17) of participants in both groups were under the care of their
GP. There were no significant differences between groups on any
of these variables. Online Table DS1 provides supplementary
demographic information concerning marital status, ethnicity,
schooling, employment, and admissions to hospital. The two
groups did not differ on any of these variables.
Baseline scores
Both groups had low levels of depression and mania at baseline,
consistent with entry criterion of being out of a current mood
episode. Scores on the BRQ and QoL.BD indicate moderate levels
61
Table 1 Demographics of participants at baseline
Treatment as usual group
(n=34)
Therapy group
(n=33) t w2 P
Age, mean (s.d.) 39.9 (10.4) 38.3 (12.8) 0.58 50.58
Gender, female: n (%) 22 (64.7) 25 (75.8) 0.98 50.34
Age of bipolar diagnosis, mean (s.d.) 37.4 (10.2) 35.9 (12.7) 70.38 50.70
Diagnosis
Bipolar I disorder, n (%) 29 (85.3) 24 (72.7) 1.60 50.21
Bipolar II disorder, n (%) 5 (14.7) 9 (27.3)
Number of previous episodes, n (%)
1–6 14 (41.2) 14 (42.4) 0.01 0.92
46 20 (58.8) 19 (57.6)
Depression (HRSD), n (%)
0–13 26 (76.5) 27 (81.8) 0.29 50.59
413 8 (23.5) 6 (18.2)
Mania (MAS), n (%)
0–20 34 (100) 33 (100)
420 0 0
Medication at baseline, n (%)
Antidepressants 17 (50) 14 (42) 0.39 50.53
Mood stabilisers 22 (65) 14 (42) 3.34 50.07
Antipsychotics 21 (62) 20 (61) 0.01 50.92
Care team, n (%)
Community mental health team 24 (71) 19 (58) 1.24 50.53
Psychiatrist 3 (9) 4 (12)
General practitioner 7 (21) 10 (30)
HRSD, Hamilton Rating Scale for Depression; MAS, Bech–Rafaelsen Mania Scale.
Table 2 Self-reported recovery, quality of life, functioning and mood by treatment group
Treatment as usual group Recovery-focused CBT group Test statistics
n Mean s.d. n Mean s.d. t P
Bipolar Recovery Questionnaire
Baseline 33 1934.57 543.85 33 1797.39 454.80 1.115 50.27
6-month follow-up 21 2082.57 518.58 26 2378.92 578.26
12-month follow-up 15 2193.40 357.74 22 2351.41 462.02
Quality of Life in Bipolar Disorder Scale
Baseline 33 36.73 11.59 33 35.91 8.76 0.32 50.75
6-month follow-up 21 38.14 14.27 26 42.30 9.03
12-month follow-up 15 39.67 7.60 22 42.27 7.34
Personal and Social Performance Scale
Baseline 33 72.45 16.80 33 67.97 18.05 0.58 50.30
6-month follow-up 18 68.50 18.67 22 75.73 19.52
12-month follow-up 16 77.13 15.78 18 78.44 18.10
Internal States Scale – Activation
Baseline 33 117.18 95.37 33 115.91 90.98 0.055 50.96
6-month follow-up 19 100.32 98.37 24 81.96 77.89
12-month follow-up 15 93.26 76.87 22 93.86 101.93
Internal States Scale – Wellbeing
Baseline 33 131.55 86.16 33 132.09 73.47 70.027 50.98
6-month follow-up 19 157.00 62.63 24 165.88 69.25
12-month follow-up 15 153.60 78.90 22 162.14 78.00
Beck Depression Inventory
Baseline 33 19.00 14.85 33 19.39 13.23 70.113 50.91
6-month follow-up 20 13.60 13.00 26 13.58 14.91
12-month follow-up 15 14.87 14.20 22 14.41 21.98
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of personal recovery and quality of life at baseline (Table 2). There
were no significant differences between groups on any of these
variables.
Primary clinical outcomes
The BRQ score was higher in the recovery-focused CBT group at
follow-up than the TAU group (310.87, 95% CI 75.00–546.74
(s.e. = 120.34), P= 0.010, d = 0.62) with no interaction between
this effect and follow-up assessment point (6 or 12 months),
indicating greater improvement in recovery after therapy,
sustained at follow-up. As Table 2 indicates, not all participants
completed self-report questionnaires at assessment points (BRQ
data 98% (n= 66) of potential sample at baseline, 90% (n= 47)
at 6 months, and 82% (n=37) at 12 months).
Follow-up relapse data were available for 58 participants (29
from each of the two treatment groups). Participants were
followed up for a period of up to 15 months during which time
32 experienced a relapse of either depression or mania (20 TAU
v. 12 recovery-focused CBT). Kaplan–Meier estimates of time to
first recurrence of either type are presented in Fig. 2. Median
survival times for the TAU and recovery-focused CBT groups were
18 (95% CI 8–40) and 56 (95% CI 28–8) weeks, respectively. The
difference in time to recurrence was statistically significant
(w2 = 7.64, P50.006, estimated HR= 0.38, 95% CI 0.18–0.78).
During follow-up, 30 patients experienced a depressive relapse
(19 TAU v. 11 recovery-focused CBT). Kaplan–Meier estimates of
time to first depressive recurrence are presented in Fig. 3. Median
survival times for the TAU and recovery-focused CBT groups were
18 (95% CI 8–47) and 60 (95% CI 29–8) weeks, respectively. The
difference in time to recurrence rates was statistically significant
(w2 = 7.63, P50.006, estimated HR= 0.37, 95% CI 0.18–0.77).
Manic relapses were less common, occurring in 13 participants
(10 TAU v. 3 recovery-focused CBT). Times to first manic
recurrence are presented in Fig. 4. Median survival times for the
TAU and recovery-focused CBT groups were 33 (95% CI 23–58)
and 60 (95% CI 53–8) weeks, respectively. This difference in
time to recurrence was statistically significant (w2 = 6.77,
P50.009, estimated HR=0.38, 95% CI 0.19–0.79).
Comparisons were also made for average mood symptoms
(HRSD and MAS) (Figs 5 and 6). There was no significant impact
of recovery-focused CBT compared with TAU on depressive
(HRSD, 70.98, 95% CI 73.66 to 1.71 (s.e. = 1.37), d=70.17)
or manic symptoms (MAS, 70.66, 95% CI 71.69 to 0.37
(s.e. = 0.53), d=70.19) across the follow-up period although
the direction of effect favoured recovery-focused CBT in both
cases: both depressive and manic symptom scores were low
throughout the study period.
Secondary clinical outcomes
Table 2 provides summary data for quality of life (QoL.BD), social
functioning (PSP) and self-reported mood symptoms (BDI and
ISS). For QoL.BD and PSP there were non-significant trends
towards greater improvements with recovery-focused CBT at
follow-up compared with TAU (QoL.BD 4.83, 95% CI 70.07 to
9.74 (s.e. = 2.50), P= 0.054, d= 0.47; PSP 6.12, 95% CI 72.22 to
14.46 (s.e. = 4.25), P=0.151, d= 0.35). There was no interaction
between either effect and follow-up points (6 or 12 months).
There was no evidence for a significant differential treatment
effect on self-reported mood symptoms, although in all cases
the direction of effect favoured recovery-focused CBT (for ISS-A
and BDI lower score, and for ISS-W higher score, indicated
improvement: ISS-A 72.79, 95% CI 737.86 to 32.27
(s.e. = 17.98), P= 0.88, d=70.03; ISS-W 8.09, 95% CI 725.32
to 41.51 (s.e. = 17.04), P=0.635, d= 0.10; BDI 70.88, 95% CI
77.59 to 5.84 (s.e. = 3.43), P= 0.798, d=70.05).
Medication adherence (number of days medication missed in
the preceding 4 weeks) was compared for antipsychotics, mood
stabilisers and antidepressants (in participants for whom these
were prescribed) at baseline, 6 months and 12 months. Self-
























Fig. 2 Kaplan–Meier estimates of time to first depressive or
manic recurrence over up to 60 weeks follow-up.























Fig. 3 Kaplan–Meier estimates of time for depressive recurrence
over up to 60 weeks follow-up.























Fig. 4 Kaplan–Meier estimates for time to first manic recurrence
over up to 60 weeks follow-up.
TAU, treatment as usual; CBT, cognitive–behavioural therapy.
Recovery-focused cognitive–behavioural therapy for bipolar disorder
means range 0–6 days missed; mood stabilisers: means range 0.2–
3.8 days missed; antipsychotics: means range 0.2–4 days missed).
No significant differences were found between recovery-focused
CBT and TAU at any assessment point.
Discussion
This is the first study to evaluate the impact of recovery-focused
CBT on recent-onset bipolar disorder. Recovery-focused CBT was
developed in partnership with individuals with lived experience of
bipolar, consistent with Mental Health Research Network good
practice guidelines.34 The high level of engagement of individuals
with personal experience of bipolar disorder is consistent with the
aims of recovery approaches7–9 to be empowering, individualised
and grounded in the individual’s own priorities and needs.
Recovery-focused CBT differs from standard CBT in having less
of a focus on relapse prevention and symptom reduction.4,35
There is also a strong emphasis on formulation, so that the client’s
route through therapy is different depending on their needs,
giving the therapist freedom to work with whatever model the
client brings but in the context of offering evidence-informed
approaches. Therapists are also encouraged to focus on issues
around functioning and comorbidity as well as mood problems,
should these be prioritised by the client.
Feasibility and effectiveness of recovery-focused CBT
Findings provide preliminary evidence in support of both feasibility
and effectiveness of recovery-focused CBT for people with recently
diagnosed bipolar disorder. With respect to feasibility, it proved
possible to recruit participants to within 93% of the target figure
of 72 within 12 months with a single whole-time equivalent
research assistant. Of the potential participants screened, a key
reason for the 7% shortfall was participants becoming unwell
between initial screening and baseline. With more time and
resources, the recruitment target would have been fully met as
there was substantial interest in recovery-focused CBT among
service users and clinicians. In total, 54% of potential participants
screened met eligibility criteria and were randomised: this
compares well with the Scott et al’s4 and Lam et al’s35 trials, for
which the figures were 17% and 48%, respectively. Retention to
follow-up assessments was balanced across both arms of the study
and within 10% of the 75% target to 12-month follow-up. Scott
et al reported retention rates of 78% to final follow-up in their
trial,4 whereas Lam et al’s data is unclear on drop-out rates post
therapy.35
Participants in the therapy arm engaged with recovery-focused
CBT, attending 14 therapy sessions on average with 32 clients
attending 56 sessions, which is comparable with previous
studies.4,35 Over 80% of clients preferred to receive therapy in
their home. Therapists reported that clients appreciated the
flexibility of home-based therapy and felt that it enhanced
engagement compared with an office-based approach. The main
challenges experienced in delivering therapy in this way were that
sessions tended to be longer and that timing of the discussion of
sensitive issues needed to negotiated flexibly (such as when there
was no other family member in the house). Both client and
therapist ratings of working alliance were consistent with clients
experiencing the therapy as worthwhile. Therapy adherence
ratings indicated that the therapy delivered was consistent with
CBT good practice principles and also with the more flexible
recovery focus of recovery-focused CBT. As the CTS-R and
Recovery Fidelity Scales were only moderately correlated, the
importance of developing tailored measures where the trial
intervention has the more flexible structure inherent in a
formulation-driven intervention is supported. Previous studies
of established bipolar disorder have not reported working alliance
data or recovery adherence but reported similar ratings for
therapist CBT competency.4
In terms of primary clinical outcomes, recovery-focused CBT
significantly improved personal ratings of recovery at both 6- and
12-month follow-up assessments, compared with TAU. The
treatment effect is moderate–large (baseline to end therapy: 30%
improvement in the recovery-focused CBT group compared with
8% in the TAU group; average item score moved from neutral to
agree in recovery-focused CBT and remained neutral in TAU)
and suggests moderate change across the BRQ domains of self-
management of health, access to personally valued activities,
seeing recovery as a lifelong process and understanding mood
experiences. Future research should aim to determine the minimal



















Fig. 5 Observer-rated depression scores on the Hamilton
Rating Scale for Depression (HRSD).
TAU, treatment as usual; CBT, cognitive–behavioural therapy.

















Fig. 6 Observer-rated mania scores on the Bech-Refaelsen
Mania Scale (MAS).
TAU, treatment as usual; CBT, cognitive–behavioural therapy.
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definitive trial. Recovery-focused CBT also significantly increased
time to any relapse and time to both depressive and manic
relapses. Median time to any relapse was increased by 38 weeks,
time to depressive relapse by 42 weeks and time to manic relapse
by 27 weeks, compared with TAU. By contrast, recovery-focused
CBT had no significant impact on observer ratings of residual
symptoms of depression or mania. Both HRSD and MAS scores
were low throughout the study – for the HRSD, the scores ranged
from mild depression to no depression across follow-ups, whereas
for the MAS, mania scores indicated absence of mania throughout
on average.
For secondary outcomes, the clinical impact of recovery-
focused CBT seemed to be marginally stronger on functional than
on symptomatic measures. Thus, quality of life and social
functioning were numerically improved in recovery-focused CBT
compared with TAU, with moderate effect sizes (baseline to end
therapy: QoL.BD average item score moved from disagree/neutral
to neutral/agree for recovery-focused CBT and neutral at both
points for TAU; PSP moved from manifest problems to mild in
recovery-focused CBT and from mild to manifest in TAU), but
differences were not statistically significant. There were no group
differences on self-reported mood. Both groups scored in the no
mania range on ISS-A throughout the study, whereas for ISS-W
both groups scored as mildly depressed at baseline, but outside
the clinical range at both follow-up points. The BDI scores
indicated mild–minimal depression throughout the study period.
Medication adherence was high across baseline and follow-up
assessments, consistent with previous reports for CBT for bipolar
disorder.35 There was no evidence for a significant difference
between groups in number of days on which medication was
missed at any assessment points so it seems unlikely that the
impact on recovery and relapse observed here are related to
medication adherence changes. There was a non-significant trend
towards fewer participants in the recovery-focused CBT group
receiving mood stabilisers at baseline. This would if anything exert
a conservative effect on the reported findings (as recovery-focused
CBT group experienced fewer relapses).
Comparison with findings from other studies
No other CBT studies have specifically explored recovery
outcomes in bipolar disorder, so direct comparisons for this
variable are not possible. Fowler et al36 reported on the effect of
an adapted CBT intervention to enhance social recovery in
psychosis, which included individuals with affective (including
bipolar disorder) and non-affective psychosis. In contrast to the
present study, Fowler et al36 reported that improvements in social
recovery (amount of time engaged in constructive/structured
activity) were limited to those with non-affective psychosis.
However, the authors argued that their subsample of participants
with affective psychosis responded strongly to TAU (active case
management), which might have masked potential benefits of
their recovery intervention.
Previous studies of CBT in bipolar disorder have varied in
their impact on time to relapse. Lam et al reported a significant
effect over 12 months,35 whereas Ball et al reported a trend37
(for depressive relapse), both favouring CBT in increasing survival
time. By contrast, neither Scott et al4 nor Meyer & Hautzinger38
identified any benefit of CBT for survival times to relapse.
Zaretsky et al39 compared CBT with a brief individual
psychoeducation intervention and reported a significant benefit
for the CBT group for number of days depressed but no
significant impact on relapse rate. A post hoc finding from Scott
et al was that more previous episodes was associated with worse
outcomes, leading to a suggestion that earlier intervention might
be more appropriate. Consistent with this, our trial of recovery-
focused CBT with individuals within 5 years of diagnosis found
strong effects on relapse at 15 months (HR= 0.38, relapse: 41%
recovery-focused CBT v. 69% TAU), consistent with 12-month
follow-up findings reported by Lam et al35 (HR= 0.40, relapse:
43.8% CBT v. 75% TAU) and higher than both Scott et al’s4
findings over 18 months (HR= 1.05, relapse: 53% CBT v. 51%
TAU) and a recent 12-month study of enhanced-relapse prevention40
(HR= 0.79, relapse: 46% enhanced-relapse prevention v. 60%
TAU). It is of interest that this was despite recovery-focused
CBT not having a primarily therapeutic focus on relapse
prevention alone. This impact on relapse was not associated with
change in residual mood symptoms (these were consistently below
clinical thresholds for HRSD and MAS throughout the trial). A
possible mechanism for improved relapse outcomes is through
improved personal recovery. As BRQ includes self-management
of health and understanding of mood experiences, these elements
may play a role in relapse prevention. However, the current study
was not designed to test this proposal so further research is
required to address this specific question. Of the CBT studies
referred to above, only Lam et al35 reported benefits in social
functioning following therapy. Zaretksy et al,39 Meyer &
Hautzinger38 and Ball et al37 reported no differences between
groups and Scott did not report outcomes with respect to social
adjustment or quality of life, although this data was collected.
There are three key areas of innovation in our study: (a) taking
a formulation-driven approach to therapy for bipolar disorder;
(b) focusing on personal recovery outcomes; and (c) targeting
recent-onset bipolar disorder. The results indicate that this flexible
approach has an impact not only on personal recovery but also on
bipolar relapse; however it is unclear which of the innovative
aspects may be contributing to the encouraging outcomes that
were observed. A definitive trial is required to formally evaluate
both the clinical efficacy and cost-effectiveness of recovery-focused
CBT and to understand more fully the mechanisms that underpin
the apparent benefits of this therapy.
Limitations
There are weaknesses in this study that would need to be
addressed in a definitive trial. The sample size is relatively small,
the study was conducted in the North West of England only
and confidence intervals for effect estimates are quite large. It
therefore remains to be seen how well the effects reported are
replicated in a large sample. We did not correct for multiple
comparisons (for example, using Bonferroni’s correction), which
may increase the risk of type I error. Additional issues are, first,
although the current study indicates benefits for CBT over TAU
alone, we do not yet have evidence for whether recovery-focused
CBT has any advantage over other forms of structured treatment
with an attention control to rule out non-specific effects as a cause
for the observed effects. Second, it was only possible to follow up a
proportion of the sample for 15 months. Longer follow-ups would
be helpful to indicate more definitively the persistence of the gains
reported here. Third, the cost-effectiveness of recovery-focused
CBT was not assessed. Although the impact on recovery and time
to recurrence suggest there may be cost savings associated with
this therapy, this needs to be empirically tested. However, and
perhaps most importantly, our trial had relatively low statistical
power. Given the trend observed in trials of specific psychological
therapies such as CBT towards reduced effect sizes with improved
study quality (such as through adequate statistical power and a
control condition that is more active than TAU), it is possible that
our effect sizes are inflated. Therefore, an adequately powered,
definitive, randomised controlled trial is required.
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Clinical implications
Recovery-focused CBT is the first therapy for bipolar disorder that
explicitly aims to enhance personal recovery outcomes as
supported by both service users and UK government policy.7–9
The current study indicates that recovery-focused CBT is feasible
and can improve personal recovery and time to relapse. This study
highlights the potential benefits of taking a formulation-based
approach to bipolar disorder, in which a range of evidence-informed
techniques are available to the clinician but the relative emphasis
given to each is determined on an individual client basis. As only
13 participants had an early age at onset (518 years), it is unclear
how effective recovery-focused CBT is likely to be for this group.
Future research
A larger-scale trial is needed to explore the cost-effectiveness of
recovery-focused CBT and to provide more reliable estimates of
the clinical benefits reported in the current study. It would also
be of interest to evaluate the extent to which this approach can
be adapted for individuals with an established course of bipolar
disorder. Although current CBT approaches have reported mixed
results with established bipolar disorder, it remains to be seen
whether the more personalised approach of recovery-focused
CBT has benefits for this group. As indicated by the current study,
outcome measurement for therapy studies in bipolar disorder
need to consider more carefully how to evaluate personal recovery
and functioning outcomes to complement evaluations of episode
recurrence.
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